Furthermore, USP8 has also been shown to be highly expressed in HCC patients, which is significantly related to bad outcomes, and the deletion of USP8 inhibits HCC cell invasion, which is expected to be a therapeutic target for HCC.15 This evidence concerns the gene USP8 and hepatocellular carcinoma.